Dr. Angus Forster has worked in medical product development and commercialization for 20 years and has overall responsibility for the research, development and operations of Vaxxas. Since joining Vaxxas in 2012, Angus has established the Vaxxas R&D and Operations teams and led six Phase I clinical studies. He brings considerable experience in pharmaceutics, formulation development, analytical science, medical device design and development, risk management and quality systems. Before joining Vaxxas, Angus worked with GlaxoSmithKline in pharmaceutical development and spent several years with PA Consulting.